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Innate immunity to Candida albicans depends upon the recognition of molecular patterns on the fungal cell
wall. However, the masking of major components such as -glucan seems to be a mechanism that fungi have
evolved to avoid immune cell recognition through the dectin-1 receptor. Although the role of C. albicans
mitogen-activated protein kinase (MAPK) pathways as virulence determinants has been established previously
with animal models, the mechanism involved in this behavior is largely unknown. In this study we demonstrate
that a disruption of the C. albicans extracellular signal-regulated kinase (ERK)-like 1 (CEK1)-mediated MAPK
pathway causes enhanced cell wall -glucan exposure, triggering immune responses more efficiently than the
wild type, as measured by dectin-1-mediated specific binding and human dendritic cell (hDC)- and macro-
phage-mediated phagocytosis, killing, and activation of intracellular signaling pathways. At the molecular level,
the disruption of CEK1 resulted in altered spleen tyrosine kinase (Syk), Raf-1, and ERK1/2 activations together
with IB degradation on hDCs and increased dectin-1-dependent activator protein 1 (AP-1) activation on
transfected cells. In addition, concurring with these altered pathways, we detected increased reactive oxygen
species production and cytokine secretion. In conclusion, the CEK1-mediated MAPK pathway is involved in
-glucan exposure in a fungal pathogen, hence influencing dectin-1-dependent immune cell recognition, thus
establishing this fungal intracellular signaling route as a promising novel therapeutic target.
Candida albicans is an opportunistic fungal pathogen that
lives as a commensal on mucosal surfaces. In immunocompro-
mised individuals this microorganism can behave as a patho-
gen, causing localized or disseminated candidiasis (41, 48). C.
albicans is a polymorphic fungus able to change from the uni-
cellular (yeast) to the mycelial (filamentous) form of growth, a
process called dimorphic transition (3). Adaptation to a changing
environment and coping with host defenses are essential for
pathogen survival, and fungal mitogen-activated protein kinase
(MAPK)-mediated signal transduction pathways are important
for performing this function (45). A disruption of the CEK1-
mediated pathway by the deletion of the CEK1 (Candida albicans
extracellular signal-regulated kinase [ERK]-like 1) MAPK or the
upstream HST7 MAPK kinase (MAPKK) genes causes defects in
invasive growth (32), and cek1 mutants are less virulent in some
animal models of candidiasis (10, 26). This route has also been
related to cell wall biogenesis, as cek1 mutants displayed hyper-
sensitivity to agents disturbing the cell wall (15, 47). However, the
molecular mechanisms mediating these effects are not clarified.
The C. albicans cell wall is a complex dynamic structure
based on a core structure of -(1,3)-glucan covalently linked to
-(1,6)-glucan and chitin and an outer layer or matrix com-
posed mainly of mannose-glycosylated proteins (42). The fun-
gal cell wall surface represents the interface between the host
and the infective pathogen. It is a valuable therapeutic target,
as its highly conserved pathogen-associated molecular patterns
(PAMPs) are recognized by different pathogen recognition
receptors (PRRs), including Toll-like receptors (TLRs) (34)
and C-type lectins (4, 23). Recognition by these PRRs medi-
ates microbial uptake and killing as well as antigen presenta-
tion and the production of proinflammatory cytokines (48).
Dectin-1 is a C-type lectin receptor (28), expressed predom-
inantly by myeloid cells, that specifically binds -(1,3)-glucan
(5, 7), a potent proinflammatory molecule that is normally
hidden by the mannoprotein coat presumably to allow fungal
escape from immune cell recognition (20, 58). As the main
nonopsonic receptor involved in fungal uptake (27), dectin-1
ligation initiates intracellular signaling through the Syk- and
CARD9-dependent pathways (25, 57), triggering different pro-
tective responses (22, 33, 36, 44). A recent study demonstrated
that dectin-1 also signals through Raf-1 and that Syk- and
Raf-1-dependent pathways converge at the level of NF-B
activation to control adaptive immunity to fungi (23). How-
ever, the generation of protective cytokine responses appears
to require the simultaneous activation of TLR2 (6, 19). Al-
though the role of dectin-1 in antifungal immunity in vivo is still
controversial (50, 54), there are strong evidences supporting its
involvement in the control of C. albicans infection (43). Most
of the in vitro studies of dectin-1 engagement have used iso-
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lated fungal components, particulate cell wall extracts (zymo-
san), or heat-killed cells as stimuli, which could not reflect the
true complexity of the response to intact live fungi. Moreover,
little is known about the relevance of -glucan recognition by
dectin-1 for the activation of the host defense in primary hu-
man cells, especially using whole live yeast cells.
In this study, we show for the first time that a disruption of
the CEK1-mediated MAPK pathway leads to altered -glucan
exposure, triggering enhanced dectin-1-mediated immune re-
sponses and further supporting a relevant role for this pathway
in C. albicans immune evasion mechanism.
MATERIALS AND METHODS
Candida albicans strains and growth conditions. Unless otherwise stated, cek1,
hst7, and cek2 indicate homozygous Ura strains CK43B-16 (10), CDH9 (32),
and BEC73 (15, 38), respectively, while CAF2 (16) and RM100 (1) were used as
wild-type (wt) strains. Yeast cells were grown in YPD rich medium (2% glucose,
2% peptone, 1% yeast extract, 2% agar [if required]) at 30°C, and stationary-
phase cells were used. Fluorescein isothiocyanate (FITC)-labeled yeast cells were
obtained as described previously (52). For UV inactivation, 2  108 cells in phos-
phate-buffered saline (PBS) were exposed to single-dose UV radiation (1.2  105
J/cm2) in a UV-DNA cross-linker. For heat inactivation, 2.5 107 cells were boiled
in PBS (20 min at 98°C).
Cell lines. Human embryonic kidney 293 T (HEK293T) and mouse macro-
phage (M) RAW 264.7 cell lines (American Type Culture Collection [ATCC])
were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM) (10%
heat-inactivated fetal calf serum [FCS], 1% penicillin-streptomycin, 4 mM glu-
tamine; Gibco). The K562 cell line (ATCC) was cultured in complete RPMI
medium (Gibco). K562 cells stably expressing dectin-1 (K562–dectin-1 cells) or
DC-SIGN (see below) were maintained with 0.7 mg/ml neomycin.
Transmission electron microscopy (TEM). Stationary-phase yeast cells were
grown and harvested by centrifugation and washed in PBS, and pellets were
prefixed in a glutaraldehyde fixative (3% glutaraldehyde in 0.1 M phosphate
buffer [pH 7.4]) for 1 h. Next, a mix with an agar solution (1.5%) was carried out,
followed by a new glutaraldehyde fixation step for 30 min. After extensive
washing with the phosphate buffer, postfixation was carried out with 1% osmium
tetroxide for 1 h. Pellets were embedded in Durcupan resin. Ultrathin sections
were stained with 2% uranyl acetate. Samples were imaged with a Zeiss EM 900
transmission microscope, and the images were recorded with a Show Scan
charge-coupled-device (CCD) camera (TRS).
Generation of stable dectin-1 transfectants in K562 cells. The dectin-1–Flag
cDNA was obtained by reverse transcription (RT)-PCR amplification from pe-
ripheral blood mononuclear cell (PBMC) total RNA with specific primers for the
full coding region of human dectin-1 plus the Flag epitope tag (underlined in the
primer sequence) on the COOH terminus: sense primer 5-CAG GGG CTC
TCA AGA ACA ATG G-3 and antisense primer 5-TTA CTT GTC ATC GTC
GTC CTT GTA GTC CAT TGA AAA CTT CTT CTC ACA AAT ACT ATA
TGA GGG-3. The resulting cDNA was cloned into the pcDNA3.1/V5-His
TOPO TA expression kit (Invitrogen). Plasmid pcDNA3.1/V5-His-Dectin-1-Flag
was transfected into K562 cells with Cell Line Nucleofector Kit V (Amaxa
Biosystems), and cells were selected by using neomycin (0.8 mg/ml). K562–
dectin-1–Flag cells were isolated by using a FACSAria cell sorter (BD-Bio-
sciences) after staining with anti-Flag monoclonal antibody (MAb) (Sigma-
Aldrich).
Generation of hMs and hDCs. Human PBMCs were isolated from healthy
donor buffy coats and purified as previously described (11, 51). Briefly, mono-
cytes were purified by magnetic cell sorting using CD14 microbeads (Miltenyi
Biotech) and cultured at 0.7  106 to 1  106 cells/ml for 7 days in RPMI
complete medium supplemented with 1,000 U/ml granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) and 1,000 U/ml interleukin-4 (IL-4) (Immu-
noTools) for human monocyte-derived dendritic cells (hDCs) or 1,000 U/ml
GM-CSF for human monocyte-derived Ms (hMs). The medium was replaced,
and new cytokines were added every 2 days.
Soluble dectin-1 production. The cDNA for the complete extracellular region
of human dectin-1 (amino acids [aa] 71 to 247, corresponding to stalk and
carbohydrate recognition domains of the receptor) was cloned upstream of the
human IgG1-Fc (Fc) genomic DNA in the mammalian expression vector pEF
(30), bearing an amino-terminal Ig() chain signal peptide. The protein was
transiently expressed in HEK293T cells transfected by the calcium phosphate
method. Culture cell supernatants containing Fc-tagged soluble proteins (sDectinFc)
were harvested, and protein secretion was quantified by enzyme-linked immu-
nosorbent assay (ELISA) with anti-Fc region antibodies (Abs) (Dako). Soluble
protein was purified by protein A chromatography and high-performance liquid
chromatography (HPLC).
Generation of anti-human dectin-1 monoclonal antibody MGD3. MAb MGD3
was generated by the immunization of BALB/c mice with a fusion protein
containing the coding region for the complete extracellular domain of human
dectin-1 cloned upstream of the Flag epitope (as for sDectinFc). Splenic B cells
from immunized mice were then fused with murine plasmacytoma P3X63-
Ag8.653 cells (ATCC) according to standard protocols (31). The MAbs were
initially selected by using supernatants screened for anti-dectin-1 activity by
ELISA based on the fusion protein used for immunization. Subsequently, selec-
tion was made by flow cytometry for the ability to recognize dectin-1 specifically
on stably transfected K562 cells and primary hDCs (see Fig. S5 in the supple-
mental material for MAb specificity characterization). MAb MGD3 was purified
by affinity chromatography with protein A-Sepharose (GE Healthcare) and was
analyzed by surface plasmon resonance (SPR) using the biosensor Biacore 3000
(GE Healthcare).
Candida albicans binding assay. Binding assays were performed as previously
described (52). Briefly, cells were washed and blocked with staining PBS (PBS
with 2% bovine serum albumin [BSA], 1% fetal calf serum [FCS], and 50 g/ml
of poly-human Ig) for 15 min at room temperature. When indicated, cells were
pretreated with laminarin (500 g/ml; Sigma-Aldrich) or MAb MGD3 (5 g/ml)
before the addition of fluorescein isothiocyanate (FITC)-labeled C. albicans (10
yeast cells:1 cell).
Phagocytic assays. The phagocytosis of yeast was performed by incubating
hMs or hDCs in medium alone or with the indicated blocking Abs (5 g/ml) for
30 min at 37°C. Next, cells were washed, and media were replaced with fresh
RPMI medium containing C. albicans-FITC-conjugated yeast cells (5 yeast
cells:1 phagocyte), followed by 15 min to up to 30 min of incubation at 37°C. Cells
were then immediately transferred onto ice and washed vigorously with cold
PBS. Cell staining was performed as previously described (37). Briefly, yeast cells
were stained with polyclonal anti-C. albicans Ab (kindly provided by C. d’Enfert),
followed by Alexa-647-labeled secondary Ab to differentiate noninternalized
yeast. After fixation and permeabilization, primary cells were stained with phal-
loidin–Alexa-568, conjugated, mounted, and analyzed with a Leica TCS-SP con-
focal microscope (Leica Microsystems). The phagocytic index was assessed by
counting the number of internalized yeast cells per 100 phagocytes.
Fungicidal assays with hDCs and hMs. Killing assays were performed as
previously described (2). Briefly, yeast cells and hDCs or hMs were coincu-
bated (1 yeast cell:20 phagocytes) for 4 h. After phagocyte lysis with water, serial
dilutions were spread over YPD agar plates for determinations of CFU after 24 h
of incubation (37°C). The killing percentage for each strain was expressed as the
percent reduction of CFU from hDC- or hM-yeast cocultures versus simulta-
neous culture containing yeast cells without phagocyte cells.
Western blot analysis. After overnight culture in serum-reduced medium, cells
were treated with lysis buffer (40 mM Tris [pH 7.6], 150 mM NaCl, 1% NP-40,
1 EDTA-free protease inhibitor cocktail, and 1 PhosSTOP phosphatase
inhibitor cocktail [Roche]), and cell lysates (40 g) were resolved by SDS-PAGE
under reducing conditions. ERK1/2, Syk, and Raf-1 activation was detected by
using antibodies specific for anti-phospho-p44/42-MAPK/anti-p44/42-MAPK
(Cell Signaling), for anti-phospho-Syk (Calbiochem)/anti-Syk MAb (Upstate),
and for anti-phospho-Raf-1 (Tyr340/341)/anti-Raf-1 Abs (Upstate, Millipore).
The levels of IB- were detected by using a polyclonal anti-IB- Ab (C-15;
Santa Cruz).
Luciferase reporter assay. HEK293T cells were transfected with a mixture of
the AP-1–Luc reporter plasmid (250 ng/105 cells) and pRL-Null (5 ng/105 cells)
(Promega) bearing a promoterless Renilla luciferase gene used to normalize all
the firefly luciferase values obtained. The reporter plasmids were transfected
together with the receptor expression vector (pCDNA3.1 Dectin-1) or empty
vector (pCDNA3.1; Invitrogen) with Fugene HD reagent (Roche) according to
the manufacturer’s instructions. Forty-eight hours later, cells were cocultured (9
to 12 h) with PBS, UV-inactivated yeast cells (50 yeast cells:1 cell), or zymosan
(200 g/ml). Luciferase activity was determined with the dual-luciferase reporter
assay system (Promega) with a luminometer (Berthold Detection Systems) and is
expressed as relative light units. The histograms show means 	 standard devia-
tions (SD) for five independent experiments. Each experiment was carried out in
duplicate, and data are presented as values relative to data for untreated cells.
Measurement of ROS. A total of 106 hMs or hDCs cultured in phenol
red-free complete RPMI medium (Gibco) were cocultured with different
stimuli for 4 h. Intracellular reactive oxygen species (ROS) levels were mea-
sured by incubating cells with 5 M 2,7-dichlorodihydrofluorescein-diacetate
(H2DCFDA; Molecular Probes) (30 min at 37°C). Cells were then washed with
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cold PBS, and ROS production was examined by flow cytometry. Data are shown
as the mean fluorescence intensities (MFIs) given by H2DCFDA in the presence
of the different C. albicans strains relative to the MFI in the presence of PBS.
Stimulation of cytokine production in hDCs. A total of 0.8  106 hDCs were
cocultured with zymosan (200 g/ml; Sigma-Aldrich) and UV-inactivated or
heat-killed C. albicans strains (50 yeast cells:1 cell). For blocking, hDCs were
preincubated (30 min at 37°C) with anti-human dectin-1 MAb (MGD3; 5 g/ml)
or a functional-grade purified IgG2a isotype control (eBiosciences) before co-
culture with UV-inactivated strains (10 yeast cells:1 cell). Controls included cells
cultured in medium alone. Supernatants were analyzed for IL-10 and tumor
necrosis factor alpha (TNF-) by using commercial ELISA pair sets (R&D and
Immunotools, respectively).
Immunofluorescence and flow cytometry. For immunofluorescence analysis,
live yeast cells were allowed to adhere onto poly-L-lysine-coated coverslips (30
min at 37°C), and after washing, cells were fixed with 3.7% paraformaldehyde (10
min at room temperature). For C. albicans cell wall staining, live, heat-killed, or
paraformaldehyde-fixed yeast cells (for immunofluorescence assays) were incu-
bated with anti--(1,3)-glucan MAb (Biosupplies) or sDectinFc with an anti-Fc
MAb (Jackson ImmunoResearch) followed by FITC (for cytometry) or Alexa-
488 (for immunofluorescence) secondary labeled antibody (Dako and Molecular
Probes, respectively). Dectin-1 cell expression was determined with MAb MGD3
followed by an FITC-labeled secondary Ab. Incubations were done at 4°C in
staining PBS. Flow cytometry analyses were performed with a FACSCalibur flow
cytometer using CellquestPro software (BD-Biosciences), and immunofluores-
cence preparations were analyzed by confocal microscopy (described above) or
a conventional Leica DMR photomicroscope with QFISH software (Leica Mi-
crosystems).
Statistical analyses. The differences between groups were analyzed by the
Mann-Whitney U test. The levels of significance between groups were set at a P
value of 
0.05, a P value of 
0.001, and a P value of 
0.0005. Unless otherwise
stated, all experiments were performed at least five times, and the data are given
as mean values 	 SD.
RESULTS
Disruption of the C. albicans CEK1-mediated MAPK path-
way alters cell wall morphology. In the fungal pathogen C.
albicans, MAPK pathways are mechanisms by which different
types of stress (oxidative, temperature, pH, and others) are
sensed and an appropriate response is developed (Fig. 1A).
The cek1 mutant is defective in the Cek1 MAPK, which par-
ticipates in cell wall construction (15) and becomes activated
during growth-associated cell wall remodeling (47). In order to
identify cell wall alterations on the cek1 mutant compared to
wild-type (wt) strain CAF2, transmission electron microscopy
(TEM) analysis was initially performed. Although cell wall
thicknesses were not significantly different between them (data
not shown), TEM micrographs revealed a less-electron-dense
cell wall on the cek1 mutant compared to wt strain CAF2 (Fig.
1B and C). This differential cell wall density on the cek1 mutant
could account for its hypersensitivity to agents disturbing the
cell wall (15) and might modify fungal detection by human
immune cells.
The C. albicans CEK1-mediated MAPK pathway controls
-glucan exposure and dectin-1-mediated fungal recognition.
Considering the C. albicans cell wall structure, we hypothe-
sized that the less electron-dense cell wall of cek1 mutants on
TEM micrographs could reflect enhanced -glucan exposure.
Flow cytometry measurements revealed that -glucan expo-
sure is significantly higher in live cek1 deletion mutants than in
wt CAF2 yeast cells (Fig. 2A). Moreover, the recognition of
the cek1 mutant by soluble Fc-tagged dectin-1 recombinant
protein (sDectinFc) was also considerably elevated (Fig. 2A),
thus demonstrating that a CEK1 mutation leads to enhanced
-glucan exposure and dectin-1 recognition. Assays with heat-
killed (HK) fungi, which show increased -glucan exposure at
the cell surface (20, 58), were used as positive controls (Fig.
2A). Confocal microscopy analysis indicated that -glucan was
found over the entire surface of the mutant, whereas wt fungi
showed a restricted pattern corresponding to the mother-
daughter septal regions (20) (Fig. 2B). A similarly increased
level of -glucan staining was seen in the upstream MAPKK
Hst7 mutant (hst7), further confirming the implication of the
CEK1-mediated MAPK route for -glucan exposure (see Fig.
S1A and S1B in the supplemental material). A tridimensional
analysis of the yeast cell wall revealed an even staining over the
FIG. 1. Candida albicans-MAPK signal transduction pathways and cell wall morphology of C. albicans wild-type CAF2 and the cek1 deletion
mutant. (A) The main elements of MAPK signal transduction pathways in C. albicans are schematized, and the physiological function of each
pathway is indicated. The CEK1-mediated MAPK pathway is highlighted. (B and C) Transmission electron micrographs of the cell wall of wt strain
CAF2 (B) and the cek1 deletion mutant (C), which lacks Cek1 MAPK. Scale bar, 100 nm.
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entire surface of the cek1 mutant when -glucan MAb was
used, whereas a patched recognition pattern was detected with
sDectinFc (Fig. 2C). In addition to the above-described delo-
calized pattern, bud scars were strongly stained, showing that
-glucan is exposed in these surface structures (Fig. 2C). For
wt fungi, the tridimensional reconstruction confirmed the re-
stricted pattern shown in Fig. 2B. Finally, in order to analyze
whether the mannoprotein content was also different on the
surface of the C. albicans strains used, concanavalin A (ConA)
staining of both the wt and the cek1 mutant was performed,
and no significant differences were found (see Fig. S2A and
S2B in the supplemental material), further supporting the spe-
cific increase of -glucan exposure on cek1 mutants. Taken
together, these data demonstrate that the disruption of the
CEK1-mediated MAPK pathway leads to enhanced -glucan
exposure, causing increased dectin-1-mediated recognition.
Dectin-1-mediated binding to C. albicans is increased spe-
cifically in cek1 mutants. To extend the above-described find-
ings at the cellular level, binding assays were performed with
K562 cells stably overexpressing dectin-1 (K562–dectin-1). As
shown in Fig. 3A, K562–dectin-1 cells bound to the cek1 mu-
tant at a significantly higher percentage than to wt yeast. More-
over, the binding of the cek1 mutant was specifically inhibited
by both the anti-human dectin-1 MAb (MGD3) (see Materials
and Methods) and the soluble glucan laminarin, confirming the
specificity of dectin-1 binding to the cek1 mutant. In contrast,
and although both Cek1 and Cek2 MAPKs are potential tar-
gets of the upstream Hst7 MAPKK (Fig. 1A), K562–dectin-1
binding to cek2 mutants was not significantly distinct from that
exhibited by the corresponding wt strain (RM100) (Fig. 3B).
Taken together, and since all strains tested were bound by
DC-SIGN to a similar extent (see Fig. S3 in the supplemental
material), these data indicate that the enhancement of the
-glucan on the yeast surface results in a specific increase of
dectin-1 recognition and confirm the involvement of the Cek1
MAPK in masking -glucan within the Candida cell wall.
Deletion of CEK1 augments phagocytosis by and suscepti-
bility to human phagocytes. Macrophages (Ms) and dendritic
cells (DCs) are strategically located at the sites of Candida
entry (mucosal surfaces and skin), being essential to initiate
antifungal innate immune responses. Phagocytosis facilitates
the removal and killing of pathogens and primes the adaptive
FIG. 2. Deletion of the CEK1-mediated MAPK pathway results in cell wall -glucan exposure and increased dectin-1 recognition. (A) Rep-
resentative flow cytometry analysis of -glucan exposure on live C. albicans wt CAF2 and cek1 deletion mutants. Light-gray-filled histograms
correspond to control antibody (Ab), dark-gray-filled histograms correspond to anti--glucan MAb or soluble dectin-1–Fc (sDectinFc), and the
empty histogram represents heat-killed positive-control yeast cells. Statistical analysis of these data is shown below and represents the mean
fluorescence intensity (MFI) 	 SD (after the subtraction of control Ab MFI). , P 
 0.001. (B) Confocal immunofluorescence analysis of
individual yeast cells showing representative differential interference contrast (DIC) (Nomarski) microscopy and fluorescence images overlaid.
Fungi were stained alternatively with anti--glucan MAb or sDectinFc followed by Alexa-488-labeled secondary Abs. (C) Confocal immunoflu-
orescence analysis of individual yeast cells stained as described above (B) showing a tridimensional reconstruction of z-stack fluorescence images.
Arrows indicate stronger-stained patches corresponding to bud scars. For CAF2 yeast cells, DIC and fluorescence image overlays are also shown.
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immune response (29). To evaluate the physiological relevance
of cek1-dependent enhanced -glucan exposure, the phagocy-
tosis of both strains (the cek1 mutant and wt CAF2) by human
monocyte-derived DCs and Ms (hDCs and hMs, respec-
tively) was analyzed, and the phagocytic index was determined
through immunomicroscopical procedures to discriminate be-
tween bound and internalized fungi (Fig. 4A and B). For both
types of phagocytes, the phagocytic index of cek1 was approx-
imately twice that of wt CAF2, with hDCs exhibiting a higher
phagocytic index than hMs (Fig. 4C and D). Strikingly, the
anti-dectin-1 MAb (MGD3) inhibited phagocytosis by both
hDCs and hMs to a similar extent (Fig. 4C and D), although
it was slightly more effective in hDCs. Moreover, it seems that
MGD3 pretreatment did not affect CAF2 uptake, while it
specifically inhibited cek1 phagocytosis. These data demon-
strate a critical role for dectin-1 in cek1 phagocytosis by both
hDCs and hMs. Regarding pathogen viability after exposure
to immune cells, killing assays revealed that the cek1 mutant
strain was up to three times more susceptible to hDCs than the
corresponding wt strain (Fig. 4E). In contrast, both strains are
equally susceptible to hM killing (Fig. 4F), in agreement with
previously reported results (2). Altogether, this set of data
indicates that the deletion of CEK1 increases -glucan expo-
sure on the Candida cell wall, giving a boost to dectin-1-de-
pendent fungal recognition and phagocytosis by both hDCs
and hMs and increasing killing by hDCs.
The C. albicans cek1 mutant promotes phosphorylation of
Syk, Raf-1, and ERK kinases inducing IB degradation in
hDCs and triggers activator protein 1 (AP-1) activation
through dectin-1. To determine the molecular basis for the
differential handling of both strains by human mononuclear
phagocytes, the dectin-1-dependent signaling pathways were
FIG. 3. Dectin-1-dependent binding to C. albicans is enhanced on cek1 mutants. (A) Binding of wt CAF2 or cek1 mutant yeast cells to wt K562
and transfected K562–dectin-1 cells. Cells were incubated with FITC-labeled C. albicans strains (10 yeast cells:1 cell) and analyzed by flow
cytometry. Bars represent percentages of cells with bound fungi (means 	 SD for eight independent experiments). Statistical analyses compared
untreated K562 cell binding to wt CAF2 with binding to the cek1 mutant (solid arrows) and also untreated K562 cell binding to the cek1 mutant
with MGD3 MAb- or laminarin (LAM)-pretreated cell binding to this mutant (dotted arrows). , P 
 0.001. The inset at the top shows flow
cytometry expression levels of dectin-1 on wt or stably transfected K562 cells (filled histogram, control MAb; empty histogram, anti-dectin-1 MAb).
The inset below shows a representative C. albicans cek1 mutant binding profile for K562–dectin-1 cells (light-gray-filled histogram) and blocking
profiles with MGD3 (gray empty histogram)- or laminarin (black empty histogram)-pretreated cells. (B) Comparative binding of K562–dectin-1
stably transfected cells to cek1 and cek2 deletion mutants and the corresponding wt strains, CAF2 and RM100, respectively. Differences between
data were not significant, unless otherwise indicated. , P 
 0.05.
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evaluated with hDCs exposed to wt and mutant yeast cells. As
shown in Fig. 5A, Syk phosphorylation was observed only after
stimulation with the cek1 mutant. Moreover, and unlike wt
yeast cells, which stimulated early but short ERK phosphory-
lation, the cek1 mutant triggered stronger and sustained ERK
activation (Fig. 5A). Furthermore, and in agreement with data
from a recent report on dectin-1-dependent Raf-1 activation
(23), the cek1 mutant activated the Raf-1-dependent signaling
pathway more strongly than did the wt. Dectin-1–C. albicans
engagement ultimately activates the transcription factor
NF-B through Syk- and Raf-1-dependent signaling pathways.
To indirectly analyze the activation levels of NF-B, we thus
FIG. 4. Phagocytosis and killing of C. albicans by human monocyte-derived dendritic cells (hDCs) and macrophages (hMs). (A and B)
Confocal microscopy images of hDCs (A) and hMs (B) showing extracellular yeast cells (blue), extracellular and internalized yeast cells (green),
and actin (red). The images shown are not representative of the results but of the method used to quantify them. (C and D) The fungal phagocytic
indices of hDCs (C) and hMs (D) exposed to wt CAF2 and the cek1 deletion mutant were measured by differential immunofluorescence labeling.
The phagocytic index was assessed by counting the number of internalized yeast cells per 100 phagocytes (at least 10 fields for each immunoflu-
orescence carried out in duplicate). Data for phagocytic assays were collected in at least three independent experiments. , P 
 0.05; , P 
 0.001.
(E and F) Killing of wt CAF2 and cek1 strains by hDCs (E) and hMs (F) after 4 h of coincubation (1 yeast cell:20 phagocytes). The killing
percentage for each strain was expressed as the percent reduction of CFU from hDC- or hM-yeast cocultures versus simultaneous cultures
containing yeast cells without phagocyte cells. Data are expressed as means 	 SD for at least five independent experiments with different donors.
Statistical analyses compared the phagocytic index of hDCs or hMs for CAF2 versus the cek1 mutant (solid arrows) and the phagocytic index
after treatment or nontreatment of primary cells with MAb MGD3 for the cek1 mutant (dotted arrows).
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studied IB- degradation on hDCs exposed to different
strains. Only cek1 yeast cells were able to induce a late (30 min)
degradation of IB, indirectly indicating NF-B activation.
Finally, previous studies reporting AP-1 activation via the dec-
tin-1/Syk pathway during fungal infection (18, 56) led us to ana-
lyze the effect of cek1 on the dectin-1-dependent activation of
AP-1. To avoid a yeast-to-hypha transition during the experiment
and to minimize cell killing, we used single-dose UV-inactivated
fungi (sufficient to inactivate the fungus while avoiding cell wall
disruption and consequent -glucan unmasking [see Fig. S4 in the
supplemental material]). Luciferase reporter assays with trans-
fected HEK293T–dectin-1 cells showed that the cek1 mutant in-
duced AP-1 activation more efficiently than did wt CAF2 cells
(Fig. 5B). As expected, C. albicans or zymosan was unable to
induce AP-1 activation in HEK293T cells, which are devoid of
dectin-1 expression. Therefore, and in agreement with its higher
dectin-1 binding ability, the cek1 mutant promotes a stronger
activation of dectin-1-initiated intracellular signaling pathways.
Deletion of the CEK1 gene leads to an augmented respira-
tory burst and enhanced dectin-1-dependent cytokine synthe-
sis. In addition to binding, phagocytosis, killing, and intracel-
lular signaling, the interaction of C. albicans with phagocytes
ultimately leads to respiratory burst activation and cytokine
release (48). Thus, we tested the abilities of the cek1 mutant
and the wt strain to induce the phagocyte respiratory burst in
hMs and hDCs. The cek1 mutant promoted a slight but
significant increase in ROS secretion compared to that of the
wt (Fig. 6A and B) in both types of cells. In addition, and in
accordance with the ERK activation observed after intracellu-
lar ROS production (17), a stronger phosphorylation of ERK
in RAW 264.7 M cells exposed to the cek1 mutant was
observed (data not shown).
Finally, since the activation of the dectin-1-dependent Syk
pathway on hDCs leads to ERK phosphorylation (Fig. 5A) and
the production of cytokines (13, 53), the effect of the cek1
mutant on hDC cytokine synthesis was evaluated. UV-inacti-
vated fungi induced lower levels of TNF- secretion than heat-
killed fungi (Fig. 6C), concurring with previous observations of
heat treatment-induced cell wall disturbances (20, 22, 58).
Nonetheless, when the C. albicans cell wall was undisturbed
(single-dose UV-treatment [see Fig. S4 in the supplemental
material]), the cek1 mutant promoted a slight but significant
increase in TNF- secretion compared to that produced by wt
yeast cells (Fig. 6C). This cytokine secretion was dectin-1 de-
pendent, as it was blocked by anti-human dectin-1 MAb
MGD3 (Fig. 6D). In addition, we also observed that Cek1-
deficient fungi induced a later and higher level of dectin-1-
mediated IL-10 production than wt yeast (Fig. 6D), and this
effect was significantly inhibited in the presence of MAb
MGD3. Therefore, the deletion of the Cek1 kinase in C. albi-
FIG. 5. Deletion of CEK1 triggers Syk, ERK, and Raf-1 phosphorylation eliciting IB degradation on hDCs and induces dectin-1-dependent
AP-1 activation on transfected cells. (A) Western blot of cell lysates from hDCs cocultured with live C. albicans strains (10 yeast cells:1 cell) blotted
with anti-phospho-Syk, -ERK, and -Raf-1 Abs versus anti-total Syk, -ERK, and -Raf-1 Abs, respectively. The bottom shows IB degradation
assayed by blotting with anti-IB- Ab. Below, flow cytometry histograms show dectin-1 expression levels of hDCs from three representative
donors (D1 to D3) (filled histogram, control Ab; empty histogram, MGD3 MAb). (B) Luciferase activity of HEK293T cells transiently transfected
with the indicated plasmids after incubation with zymosan (ZYM) or C. albicans UV-inactivated yeast cells. Luciferase activity was calculated as
firefly/Renilla luciferase activities and normalized versus the control (untreated). Bars represent relative light units (RLU) as means 	 SD for five
independent experiments, each carried out in duplicate. Statistical analyses compared the luciferase activity induction of HEK293T–dectin-1-
transfected cells exposed to the wt versus the mutant strain. , P 
 0.05. The inset shows the flow cytometry expression profile of HEK293T–
dectin-1-transfected cells (filled histogram, control Ab; empty histogram, dectin-1 staining).
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cans results in an enhancement of all the known cellular re-
sponses previously ascribed to dectin-1 ligation, establishing
this signaling route as a potential target for the modulation of
antifungal immune responses.
DISCUSSION
Candida albicans is the most common fungus causing noso-
comial infections and remains a major diagnostic and thera-
peutic challenge to the clinician (49). As the unmasking of
-glucan increases the recognition of this fungus by innate
immune cells (22, 58), the identification of genes involved in
this process has attracted research interest for the develop-
ment of new anticandidal therapies. Here we report the in-
volvement of a MAPK signaling pathway in -glucan masking
in a pathogenic fungus. We demonstrated that a Cek1 defi-
ciency enhanced -glucan exposure on the C. albicans cell wall,
leading to greater innate immune responses triggered through
dectin-1.
In the present study we detected -glucan exposure over the
entire cell wall surface on cek1 and hst7 deletion mutants,
whereas on wt yeast cells, -glucan was found only in discrete
patches. The unmasking of -glucan increased dectin-1-medi-
ated recognition, uptake, killing, and signaling by phagocytic
cells. In this regard, the activations of Syk-, Raf-1-, and ERK-
dependent pathways along with IB degradation in hDCs were
enhanced, as was dectin-1-dependent AP-1 activation in dec-
tin-1-transfected cells. As a consequence of this signaling ac-
tivation, we detected enhanced ROS production and cytokine
secretion. It is noteworthy that these data suggested that this
enhanced dectin-1-mediated immune response could explain
the attenuated virulence of cek1 mutants in animal models of
disseminated or localized candidiasis (10, 26). On the other
hand, it was previously described that under certain conditions,
the Cek1 MAPK participates in filamentation and invasion
(32). This route is also involved in cell wall biogenesis, as either
cek1 mutants or mutants defective in their phosphorylation
(hst7 or sho1) are sensitive to compounds such as Congo red,
FIG. 6. The C. albicans cek1 mutant enhances respiratory burst and dectin-1-dependent cytokine secretion. (A and B) ROS secretion analysis
of hMs (A) and hDCs (B) cocultured with UV-inactivated strains (10 yeast cells:1 cell). Asterisks indicate significant differences between
untreated and treated cells (square brackets) or between cek1 mutants and wt strain CAF2 (, P 
 0.05; , P 
 0.001; , P 
 0.0005). ROS
intracellular production is represented as the means 	 SD for at least five independent experiments. (C) Mean levels of TNF- secretion by hDCs
stimulated with zymosan (ZYM) or UV-inactivated or heat-killed C. albicans strains (50 yeast cells:1 hDC). Data are representative of data from
nine independent healthy donors (means 	 SD). (D) Mean levels of TNF- (6 h) and IL-10 (18 h) in stimulated hDCs (10 yeast cells:1 hDC) in
the presence or absence of anti-human dectin-1 MAb (MGD3). ELISA results for test conditions were averaged for six independent healthy donors
and are expressed as means 	 SD (pg/ml). Data are not significant unless otherwise indicated.
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calcofluor white, caspofungin, or zymolyase (15, 46, 47). There-
fore, it could be hypothesized that the hypersensitivity to
agents perturbing the cell wall and the increased exposure of
-glucan shown by the cek1 mutant reflected an altered cell
wall organization that could lead to a lower level of resistance
to candidacidal mechanisms. Accordingly, we found these mu-
tants to be more susceptible to hDC-mediated uptake and
killing. Moreover, the phagocytic index was notably reduced in
the presence of an anti-dectin-1 MAb, suggesting a major role
of this receptor in cek1 uptake. Outstandingly, although the
phagocytic index of the cek1 mutant by hMs was twice that of
wt CAF2, the viabilities of both strains in response to hM
killing were similar. These monocyte-derived hMs were not
previously elicited; therefore, the M cytocidal function could
be only partially activated, thus explaining the reduced hM
phagocytic index compared to that of hDCs. Moreover, al-
though dectin-1 confers the ability to phagocytose yeasts, the
level of its expression on the surface of primary hMs could be
lower than that on hDCs, since MGD3 blocking is less signif-
icant. This lower level of surface expression together with the
attenuated cytocidal function may not be sufficient to initiate
the specifically enhanced cek1 killing mechanisms observed for
hDCs. In addition, Ms express higher levels of TLRs than
DCs (39) that could mask the specific cek1 killing mediated by
dectin-1. The mosaic of PRRs that is expressed by each of
these cell types ultimately determines the type of response
elicited following the recognition of C. albicans. However, fur-
ther research into the specific regulation of yeast-killing mech-
anisms will shed light on this. Nonetheless, a CEK1 disruption
could result in additional phenotypes that cannot be excluded
as a cause of their virulence defects. These data allow us to
speculate that dectin-1/ mice should be more susceptible
than wt mice to infection with Cek1-deficient strains. However,
the outcome of experimental infections is influenced by several
mechanisms, including PRR recognition and cytokine produc-
tion, as well as other factors such as adherence to host cells and
the growth rate of the mutants. Further in vivo studies to
evaluate the relevance of -glucan unmasking on the immune
response would thus be of interest. Regarding this issue, a
recent study by Wheeler et al. (59) showed that -glucan is
progressively unmasked during infection, further supporting a
major role of dectin-1 in protective antifungal immunity.
Dectin-1 engagement by the cell wall extract zymosan in
DCs triggers Syk and ERK pathway activation (13, 44). Re-
garding Syk phosphorylation, we observed activation only after
the stimulation of hDCs with the cek1 mutant. Additionally,
cek1-induced ERK activation was sustained in comparison to
that of wt yeast. These data concur with previous observations
showing ERK phosphorylation coupled to dectin-1/Syk signal-
ing (35, 53). We also showed that the cek1 mutant induced the
Raf-1 signaling pathway (23) more strongly than the wt. Al-
though Syk activation was induced exclusively through dec-
tin-1, Raf-1 activation is induced through both dectin-1 and
DC-SIGN (24), explaining the baseline activation of hDCs
exposed to wt CAF2 cells. Finally, previous studies showed that
dectin-1 activates NF-B (19, 25) and AP-1 (56) via Syk. It thus
appears that the enhanced -glucan exposure in the cek1 mu-
tant induces increased dectin-1 recognition, leading to Syk/
ERK/Raf-1 phosphorylation, which triggers NF-B and AP-1
activation and ultimately leads to ROS production and cyto-
kine synthesis. In this regard, the cek1 mutant elicited slight
but significant TNF- secretion. In addition, significant IL-10
production from hDCs was detected, which, at later stages of
the infection, may be beneficial to resolving an inflammatory
process (13, 48). The weak cytokine response elicited by C.
albicans wt cells may prevent the recruitment of effector cells
and the elimination of the pathogen, explaining its persistence
as a commensal. Nonetheless, the biological relevance of the
slight increase in cytokine synthesis induced by the cek1 mutant
is unclear, and this increase alone might not account for the
loss of virulence, while the enhanced phagocytosis and killing
observed for hDCs may help the transition from commensal-
ism to infection.
During C. albicans infection, both yeast and filamentous
forms can be found in infected tissues, and DCs discriminate
between them, eliciting a protective response against yeast and
tolerance to hyphae through different PRRs (14). An inte-
grated model of fungal recognition has been proposed, in
which immune sensing of C. albicans requires the cooperative
recognition of mannans and glucans by PRRs (39). The out-
come of an immune response to C. albicans thus depends on
the balance of the signals generated through TLR2, TLR4,
dectin-1, MR, and DC-SIGN, among others, each of which
recognizes a different PAMP of the fungal cell wall. Both
TLR2 and TLR4 collaborate with dectin-1 to induce an in-
flammatory response (6, 12, 19, 40). Herein we showed that
dectin-1-specific activation by C. albicans occurs only when
-glucan is exposed, concurring with data from previous stud-
ies (20, 59). The enhanced uptake, killing, and cytokine syn-
thesis observed for hDCs exposed to the cek1 mutant were thus
inhibited by dectin-1 MAb MGD3, suggesting a dectin-1-de-
pendent elicitation. Nonetheless, we cannot exclude the par-
ticipation of other PRRs in this process (8, 9, 21, 24). Further
studies are needed to evaluate the complex cross talk between
dectin-1 and other PRRs in immunity to C. albicans, mainly in
the context of the in vivo recognition of intact fungi by primary
human immune cells. In this regard, we observed that re-
sponses elicited by live or UV-inactivated fungi were weaker
than those triggered by heat-killed yeast (Fig. 6B), indicating
the need for studies using whole live or suitable UV-inacti-
vated C. albicans yeasts to avoid misleading conclusions (see
Fig. S4 in the supplemental material). Moreover, convention-
ally used isolated fungal components or zymosan could not
reflect the true complexity of the response against intact live
fungi. Therefore, the preservation of cell wall structure is of
outstanding importance in elucidating the immune cell-fungus
interaction.
Finally, as we have demonstrated that increased cek1 mutant
-glucan exposure led to enhanced innate immune activation,
the CEK1-mediated MAPK pathway can be proposed as a
valuable antifungal target. Moreover, drug-induced -glucan
exposure could target fungi for recognition by natural anti--
glucan antibodies, which are detected in patients with progres-
sive fungal infection (42, 55), rendering the pathogen more
susceptible to the host immune system.
In conclusion, the present study demonstrated that the
CEK1-mediated MAPK pathway has a key role in -glucan
masking in C. albicans and that, given the high degree of
conservation in MAPK pathways, this phenomenon may be a
general mechanism of fungi to evade host recognition. Addi-
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tionally, our study highlights the value of fungal MAPK path-
ways as potential therapeutic targets in modulating the host
immune response to a pathogen.
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